Peptide mapping raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
This page was last updated on 2026-01-30 and is reviewed periodically as new material appears.
Russian regulatory authorities approved the peptide for nasal administration, and it remains listed in the national pharmacopoeia under several trade names. Documented indications include acute ischemic stroke, transient ischemic attacks, traumatic brain injury, and certain ophthalmological and neurological conditions. Physicians also prescribe it for cognitive complaints in older patients, although the evidence base for that use is thinner. Outside Russia and a few neighboring states, the substance is not an approved medicine and is sold instead as a research chemical.
Later generations of the molecule include an N-acetylated form and an amidated form, both marketed online alongside the parent peptide. These variants differ in terminal chemistry and stability, and they are frequently discussed in the same breath even though they have not been compared in controlled trials. Supply outside formal healthcare systems comes largely from laboratories that synthesize peptides to order. Purity and identity of these materials vary widely, and no single body oversees the international trade.
Semax is a synthetic heptapeptide developed in the Soviet Union during the 1980s by researchers at the Institute of Molecular Genetics in Moscow. It was designed as a truncated analog of adrenocorticotropic hormone, retaining only the fragment spanning residues four through ten. Investigators sought a peptide that would preserve the cognitive effects associated with ACTH while eliminating the hormonal stimulation of the adrenal cortex. The compound entered clinical use in Russia during the following decade.
Lyophilised powder is normally kept at -20 °C in a desiccated container, with some suppliers recommending -80 °C for long-term archival storage. Repeated freeze-thaw cycles are the most common cause of avoidable loss, so aliquoting before freezing reduces variability between working sessions. Dissolved peptide is far less stable than the dry solid and is usually prepared fresh or held briefly at 4 °C. Aqueous solutions support both hydrolysis of the backbone and oxidation of the N-terminal methionine, and these two routes dominate degradation under ordinary laboratory conditions.
Identity and purity are confirmed with reversed-phase high-performance liquid chromatography, typically monitored at 214 nanometres where the peptide bond absorbs. Mass spectrometry, either electrospray or MALDI-TOF, verifies molecular mass against the theoretical value and detects truncation or adduct formation. Amino acid analysis and peptide mapping provide additional confirmation when required. The most frequently reported impurities are deletion sequences from incomplete coupling, methionine sulfoxide from oxidation, and dimeric species formed through non-covalent aggregation. Impurity profiles depend strongly on the synthesis and purification route chosen by the producer.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic heptapeptide | Analog of an ACTH fragment |
| Amino acid length | Seven residues | Met-Glu-His-Phe-Pro-Gly-Pro |
| Origin | Moscow, 1980s | Institute of Molecular Genetics |
| Approved regions | Russia and some neighboring states | Not cleared in Western markets |
| Common trade names | Multiple national brands | Sold as a nasal formulation |
Clinical evidence consists largely of small trials with modest sample sizes, often without independent replication. Reported endpoints include cognitive scores, recovery after stroke, and visual function, but study designs vary widely and few trials meet contemporary reporting standards. Systematic reviewers have noted a high risk of bias in several of these reports. No large multicenter trial conducted outside Russia has been published. The compound is therefore best described as investigational in most jurisdictions, with its clinical role still unresolved.
Semax is a synthetic heptapeptide with the sequence Met-Glu-His-Phe-Pro-Gly-Pro. Its chain combines the first seven residues of corticotropin with a C-terminal proline-glycine-proline extension, a modification intended to slow enzymatic breakdown. The free peptide has a molecular mass near 813.9 daltons. It belongs to the class of ACTH-derived fragments studied for central nervous system activity rather than for adrenal steroid stimulation. This structural relationship to a natural hormone fragment is the usual starting point for describing the compound in the literature.
Development took place during the 1980s at institutes of the Russian Academy of Sciences, where peptide fragments of ACTH were screened for cognitive and neuroprotective effects. The compound received regulatory approval in Russia as a nasal preparation, marketed for conditions such as ischemic stroke, transient ischemic attacks, and optic nerve disorders. Registration in other countries has not followed. Most published clinical reports originate from a small number of Russian research groups, and independent replication outside that setting remains limited. The regulatory status therefore differs sharply between Russia and the rest of the world.
The peptide is prone to several degradation pathways. Oxidation of the methionine residue produces a sulfoxide that elutes close to the parent peak in many chromatographic systems. Hydrolysis of peptide bonds and deamidation of susceptible residues in related sequences also reduce purity over time. Lyophilised material kept dry at minus twenty degrees Celsius and shielded from light is the most stable form commonly described in laboratory practice.
Material sold for laboratory use varies widely in stated purity and documentation. A certificate of analysis should list the analytical method, the column and detector used, and the observed purity value. Independent verification by an outside laboratory is the practical way to confirm identity when documentation is absent or internally inconsistent. Regulatory status differs by country, and a product legal in one jurisdiction may be unapproved or controlled in another.
Semax is a synthetic seven-amino-acid peptide whose sequence extends the ACTH(4-10) fragment with a C-terminal proline-glycine-proline tripeptide. The commonly cited sequence is Met-Glu-His-Phe-Pro-Gly-Pro, giving a molecular formula near C37H51N9O10S and a molecular weight close to 813.9 g/mol. It belongs to the broader class of synthetic ACTH fragments studied for central nervous system effects rather than for adrenal steroid stimulation. In practice the material appears as a lyophilized white powder for laboratory work or as a dilute saline solution in clinical settings.
Development is attributed to researchers at the Institute of Molecular Genetics in Moscow during the early 1980s, building on earlier Soviet work with ACTH fragments. Russian regulatory approval followed for intranasal use, and the compound has remained commercially available there for decades. Most published human data originate from Russian and, later, some Eastern European clinical reports, which are not always accessible in English translation. Outside that region the material is generally handled as a research chemical rather than a licensed medicine.
Regulatory status differs sharply between jurisdictions. In Russia the peptide is registered as a prescription nasal preparation, while agencies such as the United States Food and Drug Administration have not approved it for any indication. Products sold elsewhere are typically labeled for laboratory research only, and such labels shift responsibility for safe handling to the purchaser. Because the same name covers pharmaceutical-grade nasal drops and bulk research powder, identity and purity documentation becomes the main practical concern when comparing sources.
Semax binds to melanocortin receptors and is thought to influence neuronal survival and plasticity rather than to act through the adrenal axis. Laboratory work has shown increased expression of brain-derived neurotrophic factor and nerve growth factor in treated tissue. Changes in c-Fos, a marker of neuronal activation, have also been reported. Because the peptide is rapidly degraded by peptidases, its effects are generally attributed to downstream signaling cascades rather than to sustained receptor occupancy.
Published studies are dominated by animal models of stroke, ischemia, and cognitive impairment, with a smaller number of human trials conducted in Russia. Many of the human reports are small, single-center, and published in Russian-language journals, which limits independent scrutiny. Outcome measures vary between studies and often rely on clinician-rated scales rather than objective biomarkers. Systematic reviews have noted the methodological weaknesses and called for larger, preregistered trials before firm conclusions can be drawn.
Claims about enhanced focus, memory, or mood in healthy people rest mostly on anecdotal reports and community discussion rather than on controlled data. It remains unclear whether any cognitive benefit observed in patients recovering from brain injury would extend to uninjured users. Dose-response relationships, long-term safety, and interactions with other drugs are not well characterized in the peer-reviewed literature. Questions about optimal route of administration and treatment duration likewise remain open.
The Soviets designed their first human space capsule using the same spacecraft bus as their Zenit spy satellite, forcing them to keep the details and true appearance secret until after the Vostok program was over. The craft consisted of a spherical descent module with a mass of 2.46 tonnes (5,400 lb) and a diameter of 2.3 meters (7.5 ft), with a cylindrical inner cabin housing the cosmonaut, instruments, and escape system; and a biconic instrument module with a mass of 2.27 tonnes (5,000 lb), 2.25 meters (7.4 ft) long and 2.43 meters (8.0 ft) in diameter, containing the engine system and propellant. After reentry, the cosmonaut would eject at about 7,000 meters (23,000 ft) over the USSR and descend via parachute, while the capsule would land separately, because the descent module made an extremely rough landing that could have left a cosmonaut seriously injured. The "Vostok spaceship" was first displayed at the July 1961 Tushino air show, mounted on its launch vehicle's third stage, with the nose cone in place concealing the spherical capsule. A tail section with eight fins was added in an apparent attempt to confuse western observers. This also appeared on official commemorative stamps and a documentary. The Soviets finally revealed the true appearance of their Vostok capsule at the April 1965 Moscow Economic Exhibition.
Persistent synovitis Early erosive disease Extra-articular findings (including subcutaneous rheumatoid nodules) Positive serum RF findings Positive serum anti-CCP autoantibodies Positive serum 14-3-3η (YWHAH) levels above 0.5 ng/ml Carriership of HLA-DR4 "Shared Epitope" alleles Family history of RA Poor functional status Socioeconomic factors Elevated acute phase response (erythrocyte sedimentation rate [ESR], C-reactive protein [CRP]) Increased clinical severity. Distance from primary care and specialist care in rural communities
Ultrasound-assisted extractive electrospray ionization mass spectrometry (EESI-MS) has been developed at ETH Zurich (Switzerland) by Zhu, Chingin et al., (2008) for a rapid detection of melamine in untreated food samples. Ultrasounds are used to nebulize the melamine-containing liquids into a fine spray. The spray is then ionised by extractive electrospray ionisation (EESI) and analysed using tandem mass spectrometry (MS/MS). An analysis requires 30 seconds per sample. The limit of detection of melamine is a few nanograms of melamine per gram of milk. Huang et al. (2008) have also developed at Purdue University (US) a simpler instrumentation and a faster method by using a low-temperature plasma probe to ionize the samples. The major obstacles being solved, the ESI-MS technique allows now high-throughput analysis of melamine traces in complex mixtures. The Melaminometer was a hypothetical design for a synthetic biology circuit, to be used for detecting melamine and related chemical analogues such as cyanuric acid. The conceptual project is hosted at OpenWetWare as open source biology in collaboration with DIYbio and has been discussed in various newspapers in the context of homebrew biotechnology. As of October 2009, the design has not been verified. Because melamine resin is often used in food packaging and tableware, melamine at ppm level (1 part per million) in food and beverage has been reported due to migration from melamine-containing resins.
Sources: en.wikipedia.org
=== Gastrointestinal involvement === Gastrointestinal involvement is prevalent and overlaps with systemic sclerosis. Esophageal dysfunction is the most common gastrointestinal manifestation. The condition is initially asymptomatic, with difficulty swallowing (dysphagia) being the most prevalent symptom.
=== Other types === Other types of chocolate are used in baking and confectionery. These include baking chocolate (often unsweetened), couverture chocolate (used for coating), compound chocolate (a lower-cost alternative) and modeling chocolate. Modeling chocolate is a chocolate paste made by melting chocolate and combining it with corn syrup, glucose syrup, or golden syrup.
=== Second World War === The TA's war deployment plan envisioned the divisions being deployed, as equipment became available, in waves to reinforce the British Expeditionary Force (BEF) that had already been dispatched to Europe. The TA would join regular army divisions when they had completed their training. In 1938, it was envisaged that this would take at least eight months from mobilisation. In fact, with mobilisation in September 1939, the first three TA divisions arrived to take their places in the front line by February 1940: the 48th (South Midland) Division, 50th (Northumbrian) Division and 51st (Highland) Division. In April, they were joined by five more, 12th (Eastern) Division, 23rd (2nd Northumbrian) Division, 42nd (East Lancashire) Division, 44th (Home Counties) Division and the 46th Division, making eight of the thirteen British divisions deployed, although three, 12th, 23rd, and 46th, were deployed, minus much of their equipment, and dubbed 'labour divisions' to be used for infrastructure work. In practice, all of the divisions were heavily engaged in the fighting. The 42nd, 44th, and 48th took part in the stand on the River Escaut, The 50th, 42nd, and 46th were chosen for the final stand at the perimeter of Dunkirk, despite the 46th being one of the digging" divisions with few anti-tank guns and artillery pieces.
Sources: en.wikipedia.org
"Ellerman's Labor Theory of Property and the Injustice of Capitalist Exploitation". Review of Social Economy. 59 (2): 161–183. doi:10.1080/00346760110035572. JSTOR 29770104. S2CID 144866813. Devine, Pat (November 1, 1993). "Review: Property and Contract in Economics". Economic Journal. 103 (421): 1560–1561. doi:10.2307/2234490. JSTOR 2234490. Lawson, Colin (1993). "Review: Property and Contract in Economics". The Slavonic and East European Review. 71 (4): 792–793. JSTOR 4211433. Lutz, Mark A. (1995). "Book Reviews: Property and Contract in Economics". Review of Social Economy. 53 (1): 141–147. doi:10.1080/00346769500000007. Pole, J. R. (June 1977). "Review: Slavery and Revolution: The Conscience of the Rich". The Historical Journal. 20 (2): 503–513. doi:10.1017/S0018246X00011171. JSTOR 2638543. S2CID 162624457. Smith, Stephen C. (December 1994). "Property and Contract in Economics". Journal of Comparative Economics. 19 (3): 463–466. doi:10.1006/jcec.1994.1115. Woltjer, Geert (March 1996). "Book review: Property and Contract in Economics". European Journal of Law and Economics. 3 (1): 109–112. doi:10.1007/bf00149085. S2CID 195243866.
== Fisheries == Food and Agriculture Organization of the United Nations: In 2014, Thailand ranked number 14 in the world in "marine capture" of fish (harvesting of ocean species), 1.6 million tonnes, number 15 in "inland capture" (harvesting of fresh water species), 210,293 tonnesm, number 13 in "farmed species", 934,800 tonnes, and was the fourth leading exporter of fish, with exports valued at US$6.6 billion.
== Taxonomy == Arnebia densiflora was first described by Carl Friedrich von Ledebour. It was first published in Flora Rossica Enumeratio sive Plantarum in Totivs Imperii Rossici Provinciis europaeis, Asiaticis, et americanis Hucusque Observatarum 3 (1.8): 140. 1847
== Primary chloroplast lineages == All primary chloroplasts belong to one of four chloroplast lineages—the glaucophyte chloroplast lineage, the rhodophyte ("red") chloroplast lineage, the chloroplastida ("green") chloroplast lineage, and the amoeboid Paulinella chromatophora lineage. The glaucophyte, rhodophyte, and chloroplastidian lineages are all descended from the same ancestral endosymbiotic event and are all within the group Archaeplastida.
Sources: en.wikipedia.org
It originated at the Institute of Molecular Genetics in Moscow during the 1980s. The work was carried out by a Russian research group that specialized in peptide neuropharmacology.
It is registered as a medicine in Russia and has been used clinically there for decades. No regulatory agency in Western Europe or North America has approved it for any indication.
Semax corresponds to the four-to-ten fragment of adrenocorticotropic hormone. Because it omits the first three residues, it lacks the adrenal-stimulating action of the full hormone.
Reversed-phase HPLC gives the main purity figure, most often with UV detection near 214 nanometres. Mass spectrometry then confirms the molecular mass. Together the two methods distinguish a correct sequence from a closely related impurity.